Bio Stocks™(@BioStocks):$UTHR as a result of the Court’s decision, United Therapeutics believes that it is entitled to an order instructing the FDA to withdraw approval of $LQDA's NDA for Yutrepia. It also intends to seek monetary damages for past infringement, which could include a royalty on past sales of Yutrepia.

Bio Stocks™

@BioStocks

Investor/trader focused primarily in the biopharma sector. Tweets are not investment advice and are not recommendations of any kind.

加入 February 2010

92 正在關注 72.3K 粉絲

Bio Stocks™@BioStocks

2026.09.30 23:28

$UTHR as a result of the Court’s decision, United Therapeutics believes that it is entitled to an order instructing the FDA to withdraw approval of $LQDA's NDA for Yutrepia. It also intends to seek monetary damages for past infringement, which could include a royalty on past sales of Yutrepia.